Introduksjon
Denne siden gir en grundig analyse av den kjente historikken for insidernes handelsaktiviteter for Martin P Sutter. Insidere er ledere, direktører eller betydelige investorer i et selskap. Det er ulovlig for insidere å gjøre handler i deres selskaper basert på spesifikke, ikke-offentlig informasjon. Dette betyr ikke at det er ulovlig for dem å gjøre noen handler i deres egne selskaper. Imidlertid må de rapportere alle handler til SEC via et skjema 4. Til tross for disse begrensningene, antyder akademisk forskning at insidere - generelt sett - har en tendens til å overgå markedet i sine egne selskaper.
Gjennomsnittlig handelslønnsomhet
Den gjennomsnittlige handelslønnsomheten er den gjennomsnittlige avkastningen av alle åpne markedskjøp gjort av insideren de siste tre årene. For å beregne dette, undersøker vi hvert eneste åpne marked, uplanlagte kjøp som er gjort av insideren, men dette inkluderer ikke alle handler som ble markert som en del av en 10b5-1 handelsplan. Vi beregner deretter gjennomsnittlig ytelse av disse handlene over 3, 6 og 12 måneder, gjennomsnittlig hver av disse varighetene for å generere en endelig ytelsesmåling for hver handel. Til slutt,
Dersom lønnsomheten for denne interne handelen er "N/A", har enten den interne personen ikke gjort noen åpen-markeds kjøp de siste tre årene, eller så er handlene for nylig til å beregne en pålitelig prestasjonsmåler.
Oppdateringsfrekvens: Daglig
Selskaper med rapporterte insiderposisjoner
SEC-arkiveringene indikerer at Martin P Sutter har rapporterte beholdninger av handler i følgende selskaper:
Verdipapir | Navn | Siste rapporterte høydepunkter |
---|---|---|
US:BVS / Bioventus Inc. | Director, 10% Owner | 85 241 |
US:US003CVR0169 / CONTRA ABIOMED INC | Director | 0 |
US:MDXG / MiMedx Group, Inc. | Director, 10% Owner | 23 376 623 |
US:LJPC / La Jolla Pharmaceutical Co. | Director | 8 000 |
Hvordan tolke diagrammene
De følgende diagrammene viser aksjens ytelse etter hver åpen markedstransaksjon som ikke var planlagt, utført av Martin P Sutter. Ikke-planlagte handler er handler som ikke ble gjort som en del av en 10b5-1 handelsplan. Aksjeytelsen er kartlagt som kumulativ prosentendring i aksjekursen. For eksempel, hvis en innsidehandel ble gjort 1. januar 2019, vil diagrammet vise daglig prosentendring for verdipapiret til dagens dato. Dersom aksjeprisen går fra $10 til $15 i løpet av denne tiden, vil den kumulative prosentendringen i aksjeprisen være 50%. En endring i prisen fra $10 til $20 vil være 100%, og en endring i prisen fra $10 til $5 vil være - 50%.
Til syvende og sist er målet vårt å avgjøre hvor tett insidernes handler korrelerer med overavkastninger (positiv eller negativ) i aksjekursen for å se om insidere timer sine handler for å tjene på intern informasjon. Se for deg en situasjon der en insider gjør dette. I denne situasjonen, forventer vi enten (a) positive avkastninger etter kjøp, eller (b) negative avkastninger etter salg. I tilfelle (a) KJØP-diagrammet ville vise en serie av oppadgående kurver, som indikerer positive avkastninger etter hver kjøpstransaksjon. I tilfelle (b) ville SALG-diagrammet vise en serie av nedadgående kurver, som indikerer negative avkastninger etter hver salgstransaksjon.
Imidlertid er dette alene ikke nok til å dra konklusjoner. Hvis, for eksempel, aksjeprisen for selskapet steg jevnt over mange år uten å følge en syklisk trend, ville vi forventet at alle postkjøpsdiagrammer skal ha en stigende trend. På samme måte vil ikke-sykliske nedganger over mange år resultere i nedadgående trend i post-trade diagrammer. Ingen av disse diagrammene ville antyde aktiviteter som insidertrening.
Den sterkeste indikatoren ville vært en situasjon der aksjekursen var ekstremt syklisk, og det var både positive signaler i KJØPSdiagrammet og negative plot i SALGSdiagrammet. Denne situasjonen ville vært sterkt antydende om en insider som timet handler til sin økonomiske fordel.
Internkjøp BVS / Bioventus Inc. - Analyse av kortsiktig fortjeneste
I denne seksjonen analyserer vi lønnsomheten av hvert uplanlagt, åpen-marked internsalg som er gjort i BVS / Bioventus Inc.. Denne analysen hjelper til å forstå om den interne personen regelmessig genererer unormale avkastninger, og er verdt å følge. Denne analysen gjelder ett år etter hver handel, og resultatene er teoretiske.
Følgende tabell viser de mest nylige åpne markedskjøpene som ikke var en del av en handelsplan.
Handelsdato | Ticker | Innsider | Rapporterte aksjer |
Rapportert pris |
Justerte aksjer |
Justert pris |
Kostpris | Dager til maks |
Pris ved maks |
Maks fortjeneste ($) |
Maks fortjeneste (%) |
---|---|---|---|---|---|---|---|
Det er ingen kjente uplanlagte handler på det åpne markedet for denne insideren og verdipapirkombinasjonen. |
Justert pris er prisen justert for splitt. Justerte aksjer er aksjene justert for splitt.
Internhandel BVS / Bioventus Inc. - Analyse av kortsiktig tap
I denne seksjonen analyserer vi unngåelsen av kortsiktig tap for hvert uplanlagt, åpen-marked internsalg som er gjort i BVS / Bioventus Inc.. Et jevnt mønster av tap unngåelse kan antyde at fremtidige salgstransaksjoner kan forutsi nedgang i pris. Denne analysen gjelder ett år etter hver handel, og resultatene er teoretiske.
Følgende tabell viser de mest nylige åpne markedskjøpene som ikke var en del av en handelsplan.
Handelsdato | Ticker | Innsider | Rapporterte aksjer |
Rapportert pris |
Justerte aksjer |
Justert pris |
Kostpris | Dager til min |
Pris ved min |
Maks tap unngått ($) |
Maks tap unngått (%) |
---|---|---|---|---|---|---|---|
Det er ingen kjente uplanlagte handler på det åpne markedet for denne insideren og verdipapirkombinasjonen. |
Justert pris er prisen justert for splitt. Justerte aksjer er aksjene justert for splitt.
Internkjøp MDXG / MiMedx Group, Inc. - Analyse av kortsiktig fortjeneste
I denne seksjonen analyserer vi lønnsomheten av hvert uplanlagt, åpen-marked internsalg som er gjort i BVS / Bioventus Inc.. Denne analysen hjelper til å forstå om den interne personen regelmessig genererer unormale avkastninger, og er verdt å følge. Denne analysen gjelder ett år etter hver handel, og resultatene er teoretiske.
Følgende tabell viser de mest nylige åpne markedskjøpene som ikke var en del av en handelsplan.
Handelsdato | Ticker | Innsider | Rapporterte aksjer |
Rapportert pris |
Justerte aksjer |
Justert pris |
Kostpris | Dager til maks |
Pris ved maks |
Maks fortjeneste ($) |
Maks fortjeneste (%) |
---|---|---|---|---|---|---|---|
Det er ingen kjente uplanlagte handler på det åpne markedet for denne insideren og verdipapirkombinasjonen. |
Justert pris er prisen justert for splitt. Justerte aksjer er aksjene justert for splitt.
Internhandel MDXG / MiMedx Group, Inc. - Analyse av kortsiktig tap
I denne seksjonen analyserer vi unngåelsen av kortsiktig tap for hvert uplanlagt, åpen-marked internsalg som er gjort i BVS / Bioventus Inc.. Et jevnt mønster av tap unngåelse kan antyde at fremtidige salgstransaksjoner kan forutsi nedgang i pris. Denne analysen gjelder ett år etter hver handel, og resultatene er teoretiske.
Følgende tabell viser de mest nylige åpne markedskjøpene som ikke var en del av en handelsplan.
Handelsdato | Ticker | Innsider | Rapporterte aksjer |
Rapportert pris |
Justerte aksjer |
Justert pris |
Kostpris | Dager til min |
Pris ved min |
Maks tap unngått ($) |
Maks tap unngått (%) |
---|---|---|---|---|---|---|---|
Det er ingen kjente uplanlagte handler på det åpne markedet for denne insideren og verdipapirkombinasjonen. |
Justert pris er prisen justert for splitt. Justerte aksjer er aksjene justert for splitt.
Innsidernes handelshistorikk
Tabellen viser den komplette listen over innsidehandler gjort av Martin P Sutter som avslørt til Securies Exchange Comission (SEC).
Fildato | Transaksjonsdato | Skjema | Ticker | Verdipapir | Kode | Aksjer | Gjenværende aksjer | Prosent endring |
Aksje pris |
Transaksjons verdi |
Gjenværende verdi |
|
---|---|---|---|---|---|---|---|---|---|---|---|---|
2025-06-04 |
|
4 | BVS |
Bioventus Inc.
Class A Common Stock |
M - Exercise | 26 493 | 85 241 | 45,10 | ||||
2024-06-11 |
|
4 | BVS |
Bioventus Inc.
Class A Common Stock |
M - Exercise | 30 400 | 58 748 | 107,24 | ||||
2023-06-13 |
|
4 | BVS |
Bioventus Inc.
Class A Common Stock |
M - Exercise | 16 648 | 28 348 | 142,29 | ||||
2022-12-27 |
|
4 | NASD |
ABIOMED INC
Common Stock, $0.01 par value |
D - Sale to Issuer | −123 370 | 0 | −100,00 | ||||
2022-11-17 |
|
4 | NASD |
ABIOMED INC
Common Stock, $0.01 par value |
S - Sale | X | −141 | 119 370 | −0,12 | 375,56 | −52 954 | 44 830 729 |
2022-11-17 |
|
4 | NASD |
ABIOMED INC
Common Stock, $0.01 par value |
S - Sale | X | −1 859 | 119 511 | −1,53 | 374,66 | −696 496 | 44 776 194 |
2022-11-17 |
|
4 | NASD |
ABIOMED INC
Common Stock, $0.01 par value |
S - Sale | X | −867 | 121 370 | −0,71 | 374,92 | −325 059 | 45 504 514 |
2022-11-17 |
|
4 | NASD |
ABIOMED INC
Common Stock, $0.01 par value |
S - Sale | X | −1 133 | 122 237 | −0,92 | 374,18 | −423 949 | 45 738 983 |
2022-08-17 |
|
4 | NASD |
ABIOMED INC
Common Stock, $0.01 par value |
S - Sale | X | −20 | 122 839 | −0,02 | 287,44 | −5 749 | 35 308 842 |
2022-08-17 |
|
4 | NASD |
ABIOMED INC
Common Stock, $0.01 par value |
S - Sale | X | −78 | 122 859 | −0,06 | 286,49 | −22 346 | 35 198 305 |
2022-08-17 |
|
4 | NASD |
ABIOMED INC
Common Stock, $0.01 par value |
S - Sale | X | −77 | 122 937 | −0,06 | 285,59 | −21 990 | 35 109 061 |
2022-08-17 |
|
4 | NASD |
ABIOMED INC
Common Stock, $0.01 par value |
S - Sale | X | −78 | 123 014 | −0,06 | 284,44 | −22 186 | 34 989 844 |
2022-08-17 |
|
4 | NASD |
ABIOMED INC
Common Stock, $0.01 par value |
S - Sale | X | −205 | 123 092 | −0,17 | 283,51 | −58 119 | 34 897 321 |
2022-08-17 |
|
4 | NASD |
ABIOMED INC
Common Stock, $0.01 par value |
S - Sale | X | −184 | 123 297 | −0,15 | 282,39 | −51 960 | 34 818 308 |
2022-08-17 |
|
4 | NASD |
ABIOMED INC
Common Stock, $0.01 par value |
S - Sale | X | −785 | 123 481 | −0,63 | 281,52 | −220 990 | 34 761 939 |
2022-08-17 |
|
4 | NASD |
ABIOMED INC
Common Stock, $0.01 par value |
S - Sale | X | −573 | 124 266 | −0,46 | 280,59 | −160 776 | 34 867 337 |
2022-08-17 |
|
4 | NASD |
ABIOMED INC
Common Stock, $0.01 par value |
S - Sale | X | −82 | 124 839 | −0,07 | 293,44 | −24 062 | 36 632 806 |
2022-08-17 |
|
4 | NASD |
ABIOMED INC
Common Stock, $0.01 par value |
S - Sale | X | −145 | 124 921 | −0,12 | 292,47 | −42 408 | 36 535 795 |
2022-08-17 |
|
4 | NASD |
ABIOMED INC
Common Stock, $0.01 par value |
S - Sale | X | −840 | 125 066 | −0,67 | 291,33 | −244 721 | 36 436 066 |
2022-08-17 |
|
4 | NASD |
ABIOMED INC
Common Stock, $0.01 par value |
S - Sale | X | −483 | 125 906 | −0,38 | 290,60 | −140 360 | 36 588 460 |
2022-08-17 |
|
4 | NASD |
ABIOMED INC
Common Stock, $0.01 par value |
S - Sale | X | −114 | 126 389 | −0,09 | 289,63 | −33 018 | 36 605 882 |
2022-08-17 |
|
4 | NASD |
ABIOMED INC
Common Stock, $0.01 par value |
S - Sale | X | −285 | 126 503 | −0,22 | 288,44 | −82 204 | 36 487 893 |
2022-08-17 |
|
4 | NASD |
ABIOMED INC
Common Stock, $0.01 par value |
S - Sale | X | −51 | 126 788 | −0,04 | 287,66 | −14 671 | 36 472 204 |
2022-08-12 |
|
4 | NASD |
ABIOMED INC
Common Stock, $0.01 par value |
F - Taxes | −232 | 126 839 | −0,18 | 293,34 | −68 055 | 37 206 952 | |
2022-08-12 |
|
4 | NASD |
ABIOMED INC
Common Stock, $0.01 par value |
A - Award | 681 | 127 071 | 0,54 | ||||
2022-05-19 |
|
4 | NASD |
ABIOMED INC
Common Stock, $0.01 par value |
S - Sale | X | −15 | 126 390 | −0,01 | 253,22 | −3 798 | 32 004 476 |
2022-05-19 |
|
4 | NASD |
ABIOMED INC
Common Stock, $0.01 par value |
S - Sale | X | −103 | 126 405 | −0,08 | 251,85 | −25 941 | 31 835 251 |
2022-05-19 |
|
4 | NASD |
ABIOMED INC
Common Stock, $0.01 par value |
S - Sale | X | −155 | 126 508 | −0,12 | 250,82 | −38 877 | 31 730 547 |
2022-05-19 |
|
4 | NASD |
ABIOMED INC
Common Stock, $0.01 par value |
S - Sale | X | −167 | 126 663 | −0,13 | 249,75 | −41 707 | 31 633 464 |
2022-05-19 |
|
4 | NASD |
ABIOMED INC
Common Stock, $0.01 par value |
S - Sale | X | −22 | 126 830 | −0,02 | 247,59 | −5 447 | 31 402 448 |
2022-05-19 |
|
4 | NASD |
ABIOMED INC
Common Stock, $0.01 par value |
S - Sale | X | −166 | 126 852 | −0,13 | 246,78 | −40 965 | 31 304 156 |
2022-05-19 |
|
4 | NASD |
ABIOMED INC
Common Stock, $0.01 par value |
S - Sale | X | −155 | 127 018 | −0,12 | 245,66 | −38 078 | 31 203 813 |
2022-05-19 |
|
4 | NASD |
ABIOMED INC
Common Stock, $0.01 par value |
S - Sale | X | −189 | 127 173 | −0,15 | 244,32 | −46 176 | 31 070 348 |
2022-05-19 |
|
4 | NASD |
ABIOMED INC
Common Stock, $0.01 par value |
S - Sale | X | −155 | 127 362 | −0,12 | 242,77 | −37 630 | 30 920 144 |
2022-05-19 |
|
4 | NASD |
ABIOMED INC
Common Stock, $0.01 par value |
S - Sale | X | −200 | 127 517 | −0,16 | 241,84 | −48 369 | 30 839 081 |
2022-05-19 |
|
4 | NASD |
ABIOMED INC
Common Stock, $0.01 par value |
S - Sale | X | −398 | 127 717 | −0,31 | 240,68 | −95 791 | 30 739 055 |
2022-05-19 |
|
4 | NASD |
ABIOMED INC
Common Stock, $0.01 par value |
S - Sale | X | −275 | 128 115 | −0,21 | 240,07 | −66 020 | 30 756 735 |
2022-05-19 |
|
4 | NASD |
ABIOMED INC
Common Stock, $0.01 par value |
S - Sale | X | −10 | 128 390 | −0,01 | 262,18 | −2 622 | 33 661 290 |
2022-05-19 |
|
4 | NASD |
ABIOMED INC
Common Stock, $0.01 par value |
S - Sale | X | −38 | 128 400 | −0,03 | 261,55 | −9 939 | 33 583 354 |
2022-05-19 |
|
4 | NASD |
ABIOMED INC
Common Stock, $0.01 par value |
S - Sale | X | −304 | 128 438 | −0,24 | 259,15 | −78 782 | 33 284 785 |
2022-05-19 |
|
4 | NASD |
ABIOMED INC
Common Stock, $0.01 par value |
S - Sale | X | −682 | 128 742 | −0,53 | 258,24 | −176 120 | 33 246 437 |
2022-05-19 |
|
4 | NASD |
ABIOMED INC
Common Stock, $0.01 par value |
S - Sale | X | −768 | 129 424 | −0,59 | 257,51 | −197 765 | 33 327 444 |
2022-05-19 |
|
4 | NASD |
ABIOMED INC
Common Stock, $0.01 par value |
S - Sale | X | −198 | 130 192 | −0,15 | 256,53 | −50 793 | 33 398 193 |
2022-04-05 |
|
4 | BVS |
Bioventus Inc.
Restricted Stock Units |
M - Exercise | −2 700 | 0 | −100,00 | ||||
2022-04-05 |
|
4 | BVS |
Bioventus Inc.
Class A Common Stock |
M - Exercise | 2 700 | 11 700 | 30,00 | ||||
2022-02-17 |
|
4 | ABMD |
ABIOMED INC
Common Stock, $0.01 par value |
S - Sale | X | −148 | 136 390 | −0,11 | 306,68 | −45 389 | 41 828 235 |
2022-02-17 |
|
4 | ABMD |
ABIOMED INC
Common Stock, $0.01 par value |
S - Sale | X | −185 | 136 538 | −0,14 | 305,71 | −56 556 | 41 740 650 |
2022-02-17 |
|
4 | ABMD |
ABIOMED INC
Common Stock, $0.01 par value |
S - Sale | X | −536 | 136 723 | −0,39 | 304,52 | −163 221 | 41 634 341 |
2022-02-17 |
|
4 | ABMD |
ABIOMED INC
Common Stock, $0.01 par value |
S - Sale | X | −460 | 137 259 | −0,33 | 303,65 | −139 678 | 41 678 380 |
2022-02-17 |
|
4 | ABMD |
ABIOMED INC
Common Stock, $0.01 par value |
S - Sale | X | −312 | 137 719 | −0,23 | 302,70 | −94 442 | 41 687 348 |
2022-02-17 |
|
4 | ABMD |
ABIOMED INC
Common Stock, $0.01 par value |
S - Sale | X | −159 | 138 031 | −0,12 | 301,56 | −47 948 | 41 624 739 |
2022-02-17 |
|
4 | ABMD |
ABIOMED INC
Common Stock, $0.01 par value |
S - Sale | X | −157 | 138 190 | −0,11 | 301,00 | −47 258 | 41 595 826 |
2022-02-17 |
|
4 | ABMD |
ABIOMED INC
Common Stock, $0.01 par value |
S - Sale | X | −32 | 138 347 | −0,02 | 298,50 | −9 552 | 41 296 580 |
2022-02-17 |
|
4 | ABMD |
ABIOMED INC
Common Stock, $0.01 par value |
S - Sale | X | −11 | 138 379 | −0,01 | 296,18 | −3 258 | 40 985 092 |
2022-02-17 |
|
4 | ABMD |
ABIOMED INC
Common Stock, $0.01 par value |
S - Sale | X | −23 | 134 390 | −0,02 | 324,33 | −7 460 | 43 586 709 |
2022-02-17 |
|
4 | ABMD |
ABIOMED INC
Common Stock, $0.01 par value |
S - Sale | X | −177 | 134 413 | −0,13 | 323,92 | −57 335 | 43 539 677 |
2022-02-17 |
|
4 | ABMD |
ABIOMED INC
Common Stock, $0.01 par value |
S - Sale | X | −164 | 134 590 | −0,12 | 322,86 | −52 950 | 43 454 333 |
2022-02-17 |
|
4 | ABMD |
ABIOMED INC
Common Stock, $0.01 par value |
S - Sale | X | −60 | 134 754 | −0,04 | 322,05 | −19 323 | 43 397 297 |
2022-02-17 |
|
4 | ABMD |
ABIOMED INC
Common Stock, $0.01 par value |
S - Sale | X | −24 | 134 814 | −0,02 | 321,69 | −7 721 | 43 368 882 |
2022-02-17 |
|
4 | ABMD |
ABIOMED INC
Common Stock, $0.01 par value |
S - Sale | X | −31 | 134 838 | −0,02 | 321,03 | −9 952 | 43 287 043 |
2022-02-17 |
|
4 | ABMD |
ABIOMED INC
Common Stock, $0.01 par value |
S - Sale | X | −62 | 134 869 | −0,05 | 320,10 | −19 847 | 43 172 241 |
2022-02-17 |
|
4 | ABMD |
ABIOMED INC
Common Stock, $0.01 par value |
S - Sale | X | −31 | 134 931 | −0,02 | 318,09 | −9 861 | 42 920 202 |
2022-02-17 |
|
4 | ABMD |
ABIOMED INC
Common Stock, $0.01 par value |
S - Sale | X | −54 | 134 962 | −0,04 | 316,10 | −17 070 | 42 662 082 |
2022-02-17 |
|
4 | ABMD |
ABIOMED INC
Common Stock, $0.01 par value |
S - Sale | X | −93 | 135 016 | −0,07 | 314,59 | −29 257 | 42 474 683 |
2022-02-17 |
|
4 | ABMD |
ABIOMED INC
Common Stock, $0.01 par value |
S - Sale | X | −31 | 135 109 | −0,02 | 313,57 | −9 721 | 42 366 129 |
2022-02-17 |
|
4 | ABMD |
ABIOMED INC
Common Stock, $0.01 par value |
S - Sale | X | −62 | 135 140 | −0,05 | 310,58 | −19 256 | 41 971 106 |
2022-02-17 |
|
4 | ABMD |
ABIOMED INC
Common Stock, $0.01 par value |
S - Sale | X | −4 | 135 202 | 0,00 | 309,91 | −1 240 | 41 900 452 |
2022-02-17 |
|
4 | ABMD |
ABIOMED INC
Common Stock, $0.01 par value |
S - Sale | X | −31 | 135 206 | −0,02 | 308,10 | −9 551 | 41 656 969 |
2022-02-17 |
|
4 | ABMD |
ABIOMED INC
Common Stock, $0.01 par value |
S - Sale | X | −31 | 135 237 | −0,02 | 307,27 | −9 525 | 41 554 273 |
2022-02-17 |
|
4 | ABMD |
ABIOMED INC
Common Stock, $0.01 par value |
S - Sale | X | −62 | 135 268 | −0,05 | 305,58 | −18 946 | 41 334 911 |
2022-02-17 |
|
4 | ABMD |
ABIOMED INC
Common Stock, $0.01 par value |
S - Sale | X | −159 | 135 330 | −0,12 | 304,90 | −48 479 | 41 262 036 |
2022-02-17 |
|
4 | ABMD |
ABIOMED INC
Common Stock, $0.01 par value |
S - Sale | X | −26 | 135 489 | −0,02 | 302,79 | −7 873 | 41 025 134 |
2022-02-17 |
|
4 | ABMD |
ABIOMED INC
Common Stock, $0.01 par value |
S - Sale | X | −50 | 135 515 | −0,04 | 301,70 | −15 085 | 40 884 632 |
2022-02-17 |
|
4 | ABMD |
ABIOMED INC
Common Stock, $0.01 par value |
S - Sale | X | −188 | 135 565 | −0,14 | 300,67 | −56 525 | 40 759 990 |
2022-02-17 |
|
4 | ABMD |
ABIOMED INC
Common Stock, $0.01 par value |
S - Sale | X | −313 | 135 753 | −0,23 | 299,98 | −93 893 | 40 723 022 |
2022-02-17 |
|
4 | ABMD |
ABIOMED INC
Common Stock, $0.01 par value |
S - Sale | X | −161 | 136 066 | −0,12 | 298,94 | −48 130 | 40 675 965 |
2022-02-17 |
|
4 | ABMD |
ABIOMED INC
Common Stock, $0.01 par value |
S - Sale | X | −61 | 136 227 | −0,04 | 298,02 | −18 180 | 40 598 997 |
2022-02-17 |
|
4 | ABMD |
ABIOMED INC
Common Stock, $0.01 par value |
S - Sale | X | −102 | 136 288 | −0,07 | 295,55 | −30 146 | 40 280 082 |
2022-02-17 |
|
4 | ABMD |
ABIOMED INC
Common Stock, $0.01 par value |
S - Sale | −49 | 130 390 | −0,04 | 321,61 | −15 759 | 41 934 728 | |
2022-02-17 |
|
4 | ABMD |
ABIOMED INC
Common Stock, $0.01 par value |
S - Sale | −1 153 | 130 439 | −0,88 | 320,61 | −369 661 | 41 819 826 | |
2022-02-17 |
|
4 | ABMD |
ABIOMED INC
Common Stock, $0.01 par value |
S - Sale | −147 | 131 592 | −0,11 | 316,92 | −46 587 | 41 703 505 | |
2022-02-17 |
|
4 | ABMD |
ABIOMED INC
Common Stock, $0.01 par value |
S - Sale | −798 | 131 739 | −0,60 | 316,02 | −252 184 | 41 632 119 | |
2022-02-17 |
|
4 | ABMD |
ABIOMED INC
Common Stock, $0.01 par value |
S - Sale | −48 | 132 537 | −0,04 | 313,82 | −15 063 | 41 592 761 | |
2022-02-17 |
|
4 | ABMD |
ABIOMED INC
Common Stock, $0.01 par value |
S - Sale | −193 | 132 585 | −0,15 | 312,64 | −60 339 | 41 450 884 | |
2022-02-17 |
|
4 | ABMD |
ABIOMED INC
Common Stock, $0.01 par value |
S - Sale | −346 | 132 778 | −0,26 | 311,69 | −107 846 | 41 386 132 | |
2022-02-17 |
|
4 | ABMD |
ABIOMED INC
Common Stock, $0.01 par value |
S - Sale | −254 | 133 124 | −0,19 | 310,65 | −78 904 | 41 354 372 | |
2022-02-17 |
|
4 | ABMD |
ABIOMED INC
Common Stock, $0.01 par value |
S - Sale | −328 | 133 378 | −0,25 | 309,74 | −101 593 | 41 311 835 | |
2022-02-17 |
|
4 | ABMD |
ABIOMED INC
Common Stock, $0.01 par value |
S - Sale | −424 | 133 706 | −0,32 | 308,80 | −130 930 | 41 288 092 | |
2022-02-17 |
|
4 | ABMD |
ABIOMED INC
Common Stock, $0.01 par value |
S - Sale | −260 | 134 130 | −0,19 | 307,64 | −79 986 | 41 263 378 | |
2022-02-15 |
|
4 | BVS |
Bioventus Inc.
Restricted Stock Units |
M - Exercise | −9 000 | 0 | −100,00 | ||||
2022-02-15 |
|
4 | BVS |
Bioventus Inc.
Class A Common Stock |
M - Exercise | 9 000 | 9 000 | |||||
2021-11-18 |
|
4 | ABMD |
ABIOMED INC
Common Stock, $0.01 par value |
S - Sale | −2 801 | 138 390 | −1,98 | 341,06 | −955 309 | 47 199 293 | |
2021-11-18 |
|
4 | ABMD |
ABIOMED INC
Common Stock, $0.01 par value |
S - Sale | −1 824 | 141 191 | −1,28 | 340,05 | −620 251 | 48 012 000 | |
2021-11-18 |
|
4 | ABMD |
ABIOMED INC
Common Stock, $0.01 par value |
S - Sale | −2 215 | 143 015 | −1,53 | 339,18 | −751 284 | 48 507 828 | |
2021-11-18 |
|
4 | ABMD |
ABIOMED INC
Common Stock, $0.01 par value |
S - Sale | −3 060 | 145 230 | −2,06 | 338,11 | −1 034 617 | 49 103 715 | |
2021-11-18 |
|
4 | ABMD |
ABIOMED INC
Common Stock, $0.01 par value |
S - Sale | −3 600 | 148 290 | −2,37 | 337,01 | −1 213 236 | 49 975 213 | |
2021-11-18 |
|
4 | ABMD |
ABIOMED INC
Common Stock, $0.01 par value |
S - Sale | −1 500 | 151 890 | −0,98 | 336,06 | −504 090 | 51 044 153 | |
2021-11-18 |
|
4 | ABMD |
ABIOMED INC
Common Stock, $0.01 par value |
S - Sale | X | −28 | 153 390 | −0,02 | 352,00 | −9 856 | 53 993 280 |
2021-11-18 |
|
4 | ABMD |
ABIOMED INC
Common Stock, $0.01 par value |
S - Sale | X | −400 | 153 418 | −0,26 | 346,93 | −138 772 | 53 225 307 |
2021-11-18 |
|
4 | ABMD |
ABIOMED INC
Common Stock, $0.01 par value |
S - Sale | X | −918 | 153 418 | −0,59 | 346,04 | −317 665 | 53 088 765 |
2021-11-18 |
|
4 | ABMD |
ABIOMED INC
Common Stock, $0.01 par value |
S - Sale | X | −800 | 154 736 | −0,51 | 345,05 | −276 040 | 53 391 657 |
2021-11-18 |
|
4 | ABMD |
ABIOMED INC
Common Stock, $0.01 par value |
S - Sale | X | −1 304 | 155 536 | −0,83 | 343,90 | −448 446 | 53 488 830 |
2021-11-18 |
|
4 | ABMD |
ABIOMED INC
Common Stock, $0.01 par value |
S - Sale | X | −300 | 156 840 | −0,19 | 342,65 | −102 795 | 53 741 226 |
2021-11-18 |
|
4 | ABMD |
ABIOMED INC
Common Stock, $0.01 par value |
S - Sale | X | −2 | 157 140 | 0,00 | 354,59 | −709 | 55 720 273 |
2021-11-18 |
|
4 | ABMD |
ABIOMED INC
Common Stock, $0.01 par value |
S - Sale | X | −894 | 157 142 | −0,57 | 353,77 | −316 270 | 55 592 125 |
2021-11-18 |
|
4 | ABMD |
ABIOMED INC
Common Stock, $0.01 par value |
S - Sale | X | −1 100 | 158 036 | −0,69 | 352,94 | −388 234 | 55 777 226 |
2021-11-18 |
|
4 | ABMD |
ABIOMED INC
Common Stock, $0.01 par value |
S - Sale | X | −926 | 159 136 | −0,58 | 352,01 | −325 961 | 56 017 463 |
2021-11-18 |
|
4 | ABMD |
ABIOMED INC
Common Stock, $0.01 par value |
S - Sale | X | −100 | 160 062 | −0,06 | 350,76 | −35 076 | 56 143 347 |
2021-11-18 |
|
4 | ABMD |
ABIOMED INC
Common Stock, $0.01 par value |
S - Sale | X | −100 | 160 162 | −0,06 | 349,86 | −34 986 | 56 034 277 |
2021-11-18 |
|
4 | ABMD |
ABIOMED INC
Common Stock, $0.01 par value |
S - Sale | X | −100 | 160 262 | −0,06 | 348,46 | −34 846 | 55 844 897 |
2021-11-18 |
|
4 | ABMD |
ABIOMED INC
Common Stock, $0.01 par value |
S - Sale | X | −228 | 160 362 | −0,14 | 347,84 | −79 308 | 55 780 318 |
2021-11-18 |
|
4 | ABMD |
ABIOMED INC
Common Stock, $0.01 par value |
S - Sale | X | −300 | 160 590 | −0,19 | 346,86 | −104 058 | 55 702 247 |
2021-08-19 |
|
4 | ABMD |
ABIOMED INC
Common Stock, $0.01 par value |
G - Gift | −1 000 | 160 890 | −0,62 | ||||
2021-08-19 |
|
4 | ABMD |
ABIOMED INC
Common Stock, $0.01 par value |
S - Sale | X | −100 | 161 890 | −0,06 | 335,64 | −33 564 | 54 336 760 |
2021-08-19 |
|
4 | ABMD |
ABIOMED INC
Common Stock, $0.01 par value |
S - Sale | X | −600 | 161 990 | −0,37 | 334,19 | −200 514 | 54 135 438 |
2021-08-19 |
|
4 | ABMD |
ABIOMED INC
Common Stock, $0.01 par value |
S - Sale | X | −1 781 | 162 590 | −1,08 | 333,19 | −593 411 | 54 173 362 |
2021-08-19 |
|
4 | ABMD |
ABIOMED INC
Common Stock, $0.01 par value |
S - Sale | X | −600 | 164 371 | −0,36 | 332,34 | −199 404 | 54 627 058 |
2021-08-19 |
|
4 | ABMD |
ABIOMED INC
Common Stock, $0.01 par value |
S - Sale | X | −669 | 164 971 | −0,40 | 331,06 | −221 479 | 54 615 299 |
2021-08-19 |
|
4 | ABMD |
ABIOMED INC
Common Stock, $0.01 par value |
S - Sale | X | −185 | 165 640 | −0,11 | 328,87 | −60 841 | 54 474 027 |
2021-08-19 |
|
4 | ABMD |
ABIOMED INC
Common Stock, $0.01 par value |
S - Sale | X | −470 | 165 825 | −0,28 | 328,48 | −154 386 | 54 470 196 |
2021-08-19 |
|
4 | ABMD |
ABIOMED INC
Common Stock, $0.01 par value |
S - Sale | X | −1 550 | 166 295 | −0,92 | 327,45 | −507 548 | 54 453 298 |
2021-08-19 |
|
4 | ABMD |
ABIOMED INC
Common Stock, $0.01 par value |
S - Sale | X | −800 | 167 845 | −0,47 | 326,61 | −261 288 | 54 819 855 |
2021-08-19 |
|
4 | ABMD |
ABIOMED INC
Common Stock, $0.01 par value |
S - Sale | X | −100 | 168 645 | −0,06 | 324,94 | −32 494 | 54 799 506 |
2021-08-19 |
|
4 | ABMD |
ABIOMED INC
Common Stock, $0.01 par value |
S - Sale | X | −202 | 168 745 | −0,12 | 324,36 | −65 521 | 54 734 128 |
2021-08-19 |
|
4 | ABMD |
ABIOMED INC
Common Stock, $0.01 par value |
S - Sale | X | −443 | 168 947 | −0,26 | 323,19 | −143 173 | 54 601 981 |
2021-08-13 |
|
4 | ABMD |
ABIOMED INC
Common Stock, $0.01 par value |
F - Taxes | −245 | 169 390 | −0,14 | 319,88 | −78 371 | 54 184 473 | |
2021-08-13 |
|
4 | ABMD |
ABIOMED INC
Common Stock, $0.01 par value |
A - Award | 625 | 169 635 | 0,37 | ||||
2021-05-20 |
|
4 | ABMD |
ABIOMED INC
Common Stock, $0.01 par value |
S - Sale | X | −3 750 | 169 010 | −2,17 | 267,44 | −1 002 900 | 45 200 034 |
2021-05-20 |
|
4 | ABMD |
ABIOMED INC
Common Stock, $0.01 par value |
S - Sale | X | −3 750 | 172 760 | −2,12 | 266,72 | −1 000 200 | 46 078 547 |
2021-04-05 |
|
4 | BVS |
Bioventus Inc.
Restricted Stock Units |
A - Award | 2 700 | 2 700 | |||||
2021-02-18 |
|
4 | ABMD |
ABIOMED INC
Common Stock, $0.01 par value |
S - Sale | X | −3 750 | 176 510 | −2,08 | 314,01 | −1 177 538 | 55 425 905 |
2021-02-18 |
|
4 | ABMD |
ABIOMED INC
Common Stock, $0.01 par value |
S - Sale | X | −3 750 | 180 260 | −2,04 | 330,67 | −1 240 012 | 59 606 574 |
2021-02-16 |
|
4 | BVS |
Bioventus Inc.
Restricted Stock Units |
A - Award | 9 000 | 9 000 | |||||
2021-02-11 | 3 | BVS |
Bioventus Inc.
Class A Common Stock |
13 021 324 | ||||||||
2020-11-19 |
|
4 | ABMD |
ABIOMED INC
Common Stock, $0.01 par value |
S - Sale | X | −750 | 184 010 | −0,41 | 268,34 | −201 255 | 49 377 243 |
2020-11-19 |
|
4 | ABMD |
ABIOMED INC
Common Stock, $0.01 par value |
S - Sale | X | −750 | 184 760 | −0,40 | 269,53 | −202 148 | 49 798 363 |
2020-08-28 | 3/A | MDXG |
MIMEDX GROUP, INC.
Series B Preferred Stock, par value $.001 per share |
23 376 623 | ||||||||
2020-08-28 | 3/A | MDXG |
MIMEDX GROUP, INC.
Common Stock |
500 | ||||||||
2020-08-20 |
|
4 | ABMD |
ABIOMED INC
Common Stock, $0.01 par value |
G - Gift | −750 | 185 510 | −0,40 | ||||
2020-08-20 |
|
4 | ABMD |
ABIOMED INC
Common Stock, $0.01 par value |
S - Sale | X | −750 | 186 260 | −0,40 | 312,38 | −234 285 | 58 183 899 |
2020-08-20 |
|
4 | ABMD |
ABIOMED INC
Common Stock, $0.01 par value |
G - Gift | −750 | 187 010 | −0,40 | ||||
2020-08-20 |
|
4 | ABMD |
ABIOMED INC
Common Stock, $0.01 par value |
S - Sale | X | −750 | 187 760 | −0,40 | 311,99 | −233 992 | 58 579 242 |
2020-08-14 |
|
4 | ABMD |
ABIOMED INC
Common Stock, $0.01 par value |
A - Award | 661 | 188 510 | 0,35 | ||||
2020-08-11 |
|
4 | ABMD |
ABIOMED INC
Common Stock, $0.01 par value |
F - Taxes | −390 | 187 849 | −0,21 | 314,98 | −122 842 | 59 168 678 | |
2020-05-22 |
|
4 | ABMD |
ABIOMED INC
Common Stock, $0.01 par value |
G - Gift | −700 | 188 239 | −0,37 | ||||
2020-05-06 |
|
4 | ABMD |
ABIOMED INC
Stock Option (right to buy) |
M - Exercise | −12 000 | 0 | −100,00 | ||||
2020-05-06 |
|
4 | ABMD |
ABIOMED INC
Common Stock, $0.01 par value |
S - Sale | −626 | 188 939 | −0,33 | 182,14 | −114 021 | 34 413 690 | |
2020-05-06 |
|
4 | ABMD |
ABIOMED INC
Common Stock, $0.01 par value |
S - Sale | −6 584 | 189 565 | −3,36 | 181,46 | −1 194 762 | 34 399 318 | |
2020-05-06 |
|
4 | ABMD |
ABIOMED INC
Common Stock, $0.01 par value |
S - Sale | −1 100 | 196 149 | −0,56 | 180,39 | −198 428 | 35 383 142 | |
2020-05-06 |
|
4 | ABMD |
ABIOMED INC
Common Stock, $0.01 par value |
S - Sale | −1 400 | 197 249 | −0,70 | 179,34 | −251 083 | 35 375 622 | |
2020-05-06 |
|
4 | ABMD |
ABIOMED INC
Common Stock, $0.01 par value |
S - Sale | −2 290 | 198 649 | −1,14 | 178,44 | −408 634 | 35 447 484 | |
2020-05-06 |
|
4 | ABMD |
ABIOMED INC
Common Stock, $0.01 par value |
M - Exercise | 12 000 | 200 939 | 6,35 | 9,99 | 119 880 | 2 007 381 | |
2019-08-09 |
|
4 | ABMD |
ABIOMED INC
Common Stock, $0.01 par value |
A - Award | 1 053 | 188 939 | 0,56 | ||||
2019-05-10 |
|
4 | ABMD |
ABIOMED INC
Stock Option (right to buy) |
M - Exercise | −12 000 | 0 | −100,00 | ||||
2019-05-10 |
|
4 | ABMD |
ABIOMED INC
Common Stock, $0.01 par value |
S - Sale | −900 | 187 886 | −0,48 | 262,08 | −235 874 | 49 241 576 | |
2019-05-10 |
|
4 | ABMD |
ABIOMED INC
Common Stock, $0.01 par value |
S - Sale | −566 | 188 786 | −0,30 | 261,04 | −147 748 | 49 280 546 | |
2019-05-10 |
|
4 | ABMD |
ABIOMED INC
Common Stock, $0.01 par value |
S - Sale | −1 297 | 189 352 | −0,68 | 260,10 | −337 343 | 49 249 508 | |
2019-05-10 |
|
4 | ABMD |
ABIOMED INC
Common Stock, $0.01 par value |
S - Sale | −1 100 | 190 649 | −0,57 | 259,06 | −284 963 | 49 389 015 | |
2019-05-10 |
|
4 | ABMD |
ABIOMED INC
Common Stock, $0.01 par value |
S - Sale | −801 | 191 749 | −0,42 | 257,88 | −206 566 | 49 449 114 | |
2019-05-10 |
|
4 | ABMD |
ABIOMED INC
Common Stock, $0.01 par value |
M - Exercise | 12 000 | 192 550 | 6,65 | 7,67 | 92 040 | 1 476 858 | |
2019-04-03 |
|
4 | ABMD |
ABIOMED INC
Common Stock, $0.01 par value |
A - Award | 59 | 180 550 | 0,03 | 285,59 | 16 850 | 51 563 274 | |
2019-02-15 |
|
4 | ABMD |
ABIOMED INC
Common Stock, $0.01 par value |
S - Sale | −1 081 | 180 491 | −0,60 | 361,00 | −390 241 | 65 157 251 | |
2019-02-15 |
|
4 | ABMD |
ABIOMED INC
Common Stock, $0.01 par value |
S - Sale | −8 919 | 181 572 | −4,68 | 360,23 | −3 212 869 | 65 407 228 | |
2019-02-15 |
|
4 | ABMD |
ABIOMED INC
Common Stock, $0.01 par value |
S - Sale | −5 000 | 190 491 | −2,56 | 360,00 | −1 800 000 | 68 576 760 | |
2019-02-15 |
|
4 | ABMD |
ABIOMED INC
Common Stock, $0.01 par value |
S - Sale | −5 000 | 195 491 | −2,49 | 360,00 | −1 800 000 | 70 376 760 | |
2019-02-06 |
|
4 | ABMD |
ABIOMED INC
Common Stock, $0.01 par value |
S - Sale | −5 369 | 200 491 | −2,61 | 350,00 | −1 879 150 | 70 171 850 | |
2019-02-06 |
|
4 | ABMD |
ABIOMED INC
Common Stock, $0.01 par value |
S - Sale | −616 | 205 860 | −0,30 | 345,00 | −212 520 | 71 021 700 | |
2019-02-06 |
|
4 | ABMD |
ABIOMED INC
Common Stock, $0.01 par value |
S - Sale | −4 072 | 206 476 | −1,93 | 350,05 | −1 425 390 | 72 276 242 | |
2019-02-06 |
|
4 | ABMD |
ABIOMED INC
Common Stock, $0.01 par value |
S - Sale | −2 395 | 210 548 | −1,12 | 351,46 | −841 738 | 73 998 421 | |
2019-02-06 |
|
4 | ABMD |
ABIOMED INC
Common Stock, $0.01 par value |
S - Sale | −17 548 | 212 943 | −7,61 | 350,12 | −6 143 837 | 74 554 773 | |
2019-01-03 |
|
4 | ABMD |
ABIOMED INC
Common Stock, $0.01 par value |
A - Award | −52 | 230 939 | −0,02 | 325,04 | −16 902 | 75 064 413 | |
2018-10-03 |
|
4 | ABMD |
ABIOMED INC
Common Stock, $0.01 par value |
A - Award | −38 | 230 887 | −0,02 | 449,75 | −17 090 | 103 841 428 | |
2018-09-04 |
|
4 | ABMD |
ABIOMED INC
Common Stock, $0.01 par value |
G - Gift | −1 000 | 230 849 | −0,43 | ||||
2018-08-10 |
|
4 | ABMD |
ABIOMED INC
Common Stock, $0.01 par value |
A - Award | 531 | 231 849 | 0,23 | ||||
2018-07-03 |
|
4 | ABMD |
ABIOMED INC
Common Stock, $0.01 par value |
A - Award | 41 | 231 318 | 0,02 | 409,05 | 16 771 | 94 620 628 | |
2018-05-25 |
|
4 | ABMD |
ABIOMED INC
Common Stock, $0.01 par value |
G - Gift | −1 200 | 186 833 | −0,64 | ||||
2018-05-09 |
|
4 | ABMD |
ABIOMED INC
Stock Option (right to buy) |
M - Exercise | −12 000 | 0 | −100,00 | ||||
2018-05-09 |
|
4 | ABMD |
ABIOMED INC
Stock option (right to buy) |
M - Exercise | −25 000 | 0 | −100,00 | ||||
2018-05-09 |
|
4 | ABMD |
ABIOMED INC
Common Stock, $0.01 par value |
D - Sale to Issuer | −201 818 | 745 000 | −21,32 | 329,01 | −66 400 140 | 245 112 450 | |
2018-05-09 |
|
4 | ABMD |
ABIOMED INC
Common Stock, $0.01 par value |
A - Award | 6 546 | 188 033 | 3,61 | 329,01 | 2 153 699 | 61 864 737 | |
2018-05-09 |
|
4 | ABMD |
ABIOMED INC
Common Stock, $0.01 par value |
S - Sale | −400 | 181 487 | −0,22 | 346,26 | −138 505 | 62 842 142 | |
2018-05-09 |
|
4 | ABMD |
ABIOMED INC
Common Stock, $0.01 par value |
S - Sale | −700 | 181 887 | −0,38 | 345,38 | −241 765 | 62 819 877 | |
2018-05-09 |
|
4 | ABMD |
ABIOMED INC
Common Stock, $0.01 par value |
S - Sale | −1 900 | 182 587 | −1,03 | 344,55 | −654 637 | 62 909 584 | |
2018-05-09 |
|
4 | ABMD |
ABIOMED INC
Common Stock, $0.01 par value |
S - Sale | −5 300 | 184 487 | −2,79 | 343,66 | −1 821 417 | 63 401 448 | |
2018-05-09 |
|
4 | ABMD |
ABIOMED INC
Common Stock, $0.01 par value |
S - Sale | −2 700 | 189 787 | −1,40 | 342,67 | −925 197 | 65 033 457 | |
2018-05-09 |
|
4 | ABMD |
ABIOMED INC
Common Stock, $0.01 par value |
S - Sale | −200 | 192 487 | −0,10 | 341,84 | −68 368 | 65 799 756 | |
2018-05-09 |
|
4 | ABMD |
ABIOMED INC
Common Stock, $0.01 par value |
S - Sale | −800 | 192 687 | −0,41 | 340,42 | −272 334 | 65 594 027 | |
2018-05-09 |
|
4 | ABMD |
ABIOMED INC
Common Stock, $0.01 par value |
M - Exercise | 12 000 | 193 487 | 6,61 | 18,63 | 223 560 | 3 604 663 | |
2018-05-09 |
|
4 | ABMD |
ABIOMED INC
Common Stock, $0.01 par value |
S - Sale | −283 | 181 487 | −0,16 | 346,54 | −98 072 | 62 893 249 | |
2018-05-09 |
|
4 | ABMD |
ABIOMED INC
Common Stock, $0.01 par value |
S - Sale | −400 | 181 770 | −0,22 | 345,64 | −138 255 | 62 826 528 | |
2018-05-09 |
|
4 | ABMD |
ABIOMED INC
Common Stock, $0.01 par value |
S - Sale | −1 400 | 182 170 | −0,76 | 344,69 | −482 568 | 62 792 432 | |
2018-05-09 |
|
4 | ABMD |
ABIOMED INC
Common Stock, $0.01 par value |
S - Sale | −3 950 | 183 570 | −2,11 | 343,77 | −1 357 896 | 63 106 079 | |
2018-05-09 |
|
4 | ABMD |
ABIOMED INC
Common Stock, $0.01 par value |
S - Sale | −2 757 | 187 520 | −1,45 | 342,79 | −945 085 | 64 280 862 | |
2018-05-09 |
|
4 | ABMD |
ABIOMED INC
Common Stock, $0.01 par value |
S - Sale | −400 | 190 277 | −0,21 | 342,00 | −136 799 | 65 074 049 | |
2018-05-09 |
|
4 | ABMD |
ABIOMED INC
Common Stock, $0.01 par value |
S - Sale | −700 | 190 677 | −0,37 | 340,47 | −238 329 | 64 919 874 | |
2018-05-09 |
|
4 | ABMD |
ABIOMED INC
Common Stock, $0.01 par value |
M - Exercise | 25 000 | 191 377 | 15,03 | 13,91 | 347 750 | 2 662 054 | |
2018-04-03 |
|
4 | ABMD |
ABIOMED INC
Common Stock, $0.01 par value |
A - Award | 58 | 166 377 | 0,03 | 290,99 | 16 877 | 48 414 043 | |
2018-01-03 |
|
4 | ABMD |
ABIOMED INC
Common Stock, $0.01 par value |
A - Award | 90 | 166 319 | 0,05 | 187,41 | 16 867 | 31 169 844 | |
2017-10-04 |
|
4 | ABMD |
ABIOMED INC
Common Stock, $0.01 par value |
A - Award | 100 | 166 229 | 0,06 | 168,60 | 16 860 | 28 026 209 | |
2017-08-11 |
|
4 | ABMD |
ABIOMED INC
Common Stock, $0.01 par value |
A - Award | 1 283 | 166 129 | 0,78 | ||||
2017-07-05 |
|
4 | ABMD |
ABIOMED INC
Common Stock, $0.01 par value |
A - Award | 117 | 164 843 | 0,07 | ||||
2017-04-13 |
|
4 | ABMD |
ABIOMED INC
Common Stock, $0.01 par value |
A - Award | 135 | 164 726 | 0,08 | ||||
2017-01-04 |
|
4 | ABMD |
ABIOMED INC
Common Stock, $0.01 par value |
A - Award | 150 | 164 591 | 0,09 | ||||
2016-10-04 |
|
4 | ABMD |
ABIOMED INC
Common Stock, $0.01 par value |
A - Award | 131 | 164 441 | 0,08 | ||||
2016-08-11 |
|
4 | ABMD |
ABIOMED INC
Common Stock, $0.01 par value |
A - Award | 1 621 | 164 312 | 1,00 | ||||
2016-07-05 |
|
4 | ABMD |
ABIOMED INC
Common Stock, $0.01 par value |
A - Award | 148 | 162 691 | 0,09 | 109,29 | 16 175 | 17 780 499 | |
2016-04-04 |
|
4 | ABMD |
ABIOMED INC
Common Stock, $0.01 par value |
A - Award | 171 | 162 543 | 0,11 | 94,81 | 16 213 | 15 410 702 | |
2016-01-05 |
|
4 | ABMD |
ABIOMED INC
Common Stock, $0.01 par value |
A - Award | 180 | 162 372 | 0,11 | 90,28 | 16 250 | 14 658 944 | |
2015-10-02 |
|
4 | ABMD |
ABIOMED INC
Common Stock, $0.01 par value |
A - Award | 175 | 162 192 | 0,11 | 92,76 | 16 233 | 15 044 930 | |
2015-08-14 |
|
4 | ABMD |
ABIOMED INC
Common Stock, $0.01 par value |
A - Award | 3 900 | 162 017 | 2,47 | ||||
2015-07-06 |
|
4 | ABMD |
ABIOMED INC
Common Stock, $0.01 par value |
A - Award | 248 | 158 117 | 0,16 | 65,73 | 16 301 | 10 393 030 | |
2015-06-02 |
|
4 | ABMD |
ABIOMED INC
Common Stock, $0.01 par value |
P - Purchase | 7 500 | 157 869 | 4,99 | 60,17 | 451 275 | 9 498 978 | |
2015-06-02 |
|
4 | ABMD |
ABIOMED INC
Common Stock, $0.01 par value |
J - Other | 24 747 | 150 369 | 19,70 | 67,74 | 1 676 362 | 10 185 996 | |
2015-04-02 |
|
4 | ABMD |
ABIOMED INC
Common Stock, $0.01 par value |
A - Award | 226 | 125 622 | 0,18 | 71,58 | 16 177 | 8 992 023 | |
2015-01-06 |
|
4 | ABMD |
ABIOMED INC
Common Stock, $0.01 par value |
A - Award | 427 | 125 396 | 0,34 | 38,06 | 16 252 | 4 772 572 | |
2014-10-02 |
|
4 | ABMD |
ABIOMED INC
Common Stock, $0.01 par value |
A - Award | 655 | 124 969 | 0,53 | 24,83 | 16 264 | 3 102 980 | |
2014-08-15 |
|
4 | ABMD |
ABIOMED INC
Common Stock, $0.01 par value |
A - Award | 7 740 | 124 314 | 6,64 | ||||
2014-07-02 |
|
4 | ABMD |
ABIOMED INC
Common Stock, $0.01 par value |
A - Award | 646 | 116 574 | 0,56 | ||||
2014-06-03 |
|
4 | ABMD |
ABIOMED INC
Common Stock, $0.01 par value |
A - Award | 5 000 | 115 928 | 4,51 | 22,63 | 113 151 | 2 623 474 | |
2014-05-23 |
|
4 | ABMD |
ABIOMED INC
Common Stock, $0.01 par value |
A - Award | 10 000 | 110 928 | 9,91 | 20,90 | 209 000 | 2 318 395 | |
2014-04-02 |
|
4 | ABMD |
ABIOMED INC
Common Stock, $0.01 par value |
A - Award | 625 | 100 928 | 0,62 | ||||
2014-01-10 |
|
4 | ABMD |
ABIOMED INC
Common Stock, $0.01 par value |
A - Award | 607 | 100 303 | 0,61 | ||||
2013-10-02 |
|
4 | ABMD |
ABIOMED INC
Common Stock, $0.01 par value |
A - Award | 852 | 99 696 | 0,86 | ||||
2013-08-16 |
|
4 | ABMD |
ABIOMED INC
Common Stock, $0.01 par value |
A - Award | 7 740 | 98 844 | 8,50 | ||||
2013-07-02 |
|
4 | ABMD |
ABIOMED INC
Common Stock, $0.01 par value |
A - Award | 760 | 91 104 | 0,84 | ||||
2013-04-02 |
|
4 | ABMD |
ABIOMED INC
Common Stock, $0.01 par value |
A - Award | 683 | 90 344 | 0,76 | ||||
2013-01-14 |
|
4 | ABMD |
ABIOMED INC
Common Stock, $0.01 par value |
A - Award | 949 | 89 661 | 1,07 | ||||
2012-10-02 |
|
4 | ABMD |
ABIOMED INC
Common Stock, $0.01 par value |
A - Award | 608 | 88 712 | 0,69 | ||||
2012-08-10 |
|
4 | ABMD |
ABIOMED INC
Common Stock, $0.01 par value |
A - Award | 5 333 | 88 104 | 6,44 | ||||
2012-07-03 |
|
4 | ABMD |
ABIOMED INC
Common Stock, $0.01 par value |
A - Award | 558 | 82 771 | 0,68 | ||||
2012-06-18 |
|
4 | ABMD |
ABIOMED INC
Common Stock, $0.01 par value |
A - Award | 575 | 82 213 | 0,70 | ||||
2012-01-06 |
|
4 | ABMD |
ABIOMED INC
Common Stock, $0.01 par value |
A - Award | 487 | 81 638 | 0,60 | ||||
2011-10-05 |
|
4 | ABMD |
ABIOMED INC
Common Stock, $0.01 par value |
A - Award | 1 632 | 81 151 | 2,05 | ||||
2011-08-12 |
|
4 | ABMD |
ABIOMED INC
Common Stock, $0.01 par value |
A - Award | 5 333 | 79 519 | 7,19 | ||||
2011-08-09 |
|
4 | ABMD |
ABIOMED INC
Common Stock, $0.01 par value |
A - Award | 5 000 | 74 186 | 7,23 | 11,18 | 55 900 | 829 399 | |
2011-04-06 |
|
4 | ABMD |
ABIOMED INC
Common Stock, $0.01 par value |
A - Award | 1 032 | 69 186 | 1,51 | 14,53 | 14 995 | 1 005 273 | |
2010-08-13 |
|
4 | ABMD |
ABIOMED INC
Stock Option (right to buy) |
A - Award | 12 000 | 12 000 | |||||
2010-04-15 |
|
4 | ABMD |
ABIOMED INC
Common Stock, $0.01 par value |
A - Award | 1 453 | 68 154 | 2,18 | 10,32 | 14 995 | 703 349 | |
2009-08-14 |
|
4 | ABMD |
ABIOMED INC
Stock Option (right to buy) |
A - Award | 12 000 | 12 000 | 7,67 | 92 040 | 92 040 | ||
2008-08-15 |
|
4 | ABMD |
ABIOMED INC
Stock Option (right to buy) |
A - Award | 12 000 | 12 000 | 18,63 | 223 560 | 223 560 | ||
2008-05-22 | 3 | ABMD |
ABIOMED INC
Common Stock, $.01 par value |
15 000 | ||||||||
2008-05-22 | 3 | ABMD |
ABIOMED INC
Common Stock, $.01 par value |
781 818 | ||||||||
2008-05-22 | 3 | ABMD |
ABIOMED INC
Common Stock, $.01 par value |
1 818 182 | ||||||||
2008-05-22 |
|
4 | ABMD |
ABIOMED INC
Stock Option (right to buy) |
A - Award | 25 000 | 250 000 | 11,11 | 13,91 | 347 750 | 3 477 500 | |
2006-05-22 |
|
4 | LJPC |
LA JOLLA PHARMACEUTICAL CO
Stock Option (right to buy) |
A - Award | 8 000 | 8 000 | |||||
2006-05-22 |
|
4 | LJPC |
LA JOLLA PHARMACEUTICAL CO
Stock Option (right to buy) |
A - Award | 2 000 | 2 000 |